Join key stakeholders from academia, biotech, pharma and the investment community to create a roadmap for solving key translational issues in important emerging areas of drug discovery and development. This year's summit will focus on four areas where recent progress is rapidly changing the translational playing field: non-coding RNAs, chimeric antigen receptor-based cell therapies, new models in neurological disease and emerging targets in epigenetics. Panel topics to be presented are: - Non-coding RNAs as tools and targets
- New models in neurological disease
- CAR-based cellular therapies
- Epigenetics' second wind
Organizers: - Gaspar Taroncher-Oldenburg (SciBX, Nature Publishing Group, USA)
- Karen Bernstein (SciBX , BioCentury, USA)
- Steven Edelson (SciBX, BioCentury, USA)
Speakers: - Stewart Abbot
- James Audia
- Gwendolyn Binder-Scholl
- Bruce Booth
- Renier Brentjens
- Daniela Brunner
- Laurence Cooper
- David Corey
- Jean-Francois Formela
- Magali Haas
- Art Krieg
- Art Levin
- John Maraganore
- Ken Rhodes
- Charles Roberts
- Mustafa Sahin
- Stuart Schreiber
- Thomas Schuetz
- Laura Sepp-Lorenzino
- Jesse Smith
- Mriganka Sur
- Peter Tummino
| When October 29-30, 2013 Where The Colonnade Hotel Boston, MA, USA Advisory Council |
No comments:
Post a Comment